Waters Parkerson & Co., LLC Pfizer Inc Transaction History

Waters Parkerson & Co., LLC

$1.88 Billion
Q2 2024

A detailed history of Waters Parkerson & Co., LLC transactions in Pfizer Inc stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 173,632 shares of PFE stock, worth $4.88 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

173,632

Previous 188,570 7.92%

Holding current value

$4.88 Million

Previous $5.23 Million 7.17%

% of portfolio

0.26%

Previous 0.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $377,333 - $442,164	-14,938 Reduced 7.92%	173,632 $4.86 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $660,609 - $758,590	-25,516 Reduced 11.92%	188,570 $5.23 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $925,498 - $1.2 Million	-35,419 Reduced 14.2%	214,086 $6.16 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $913,056 - $1.07 Million	-28,453 Reduced 10.24%	249,505 $8.28 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $437,377 - $506,035	-12,109 Reduced 4.17%	277,958 $10.2 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $176,112 - $229,272	-4,471 Reduced 1.52%	290,067 $11.8 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $138,025 - $180,177	-3,306 Reduced 1.11%	294,538 $15.1 Million
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $100,560 - $122,759	-2,298 Reduced 0.77%	297,844 $13 Million
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $96,130 - $113,981	-2,066 Reduced 0.68%	300,142 $15.7 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $137,982 - $170,977	-3,016 Reduced 0.99%	302,208 $15.6 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $865,736 - $1.28 Million	-20,952 Reduced 6.42%	305,224 $18 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $369,146 - $474,200	-9,405 Reduced 2.8%	326,176 $14 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $172,188 - $195,060	-4,795 Reduced 1.41%	335,581 $13.1 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $1.02 Million - $1.15 Million	-30,416 Reduced 8.2%	340,376 $12.3 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $174,880 - $222,376	-5,225 Reduced 1.39%	370,792 $13.6 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $584,771 - $686,070	-18,418 Reduced 4.67%	376,017 $13.8 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $15,240 - $18,489	-506 Reduced 0.13%	394,435 $12.9 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $74,197 - $106,011	-2,745 Reduced 0.69%	394,941 $12.9 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $82,332 - $93,437	-2,501 Reduced 0.62%	397,686 $15.6 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $248,613 - $322,378	-7,652 Reduced 1.88%	400,187 $14.4 Million
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $9,947 - $11,168	-269 Reduced 0.07%	407,839 $17.7 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $392,287 - $430,993	-10,461 Reduced 2.5%	408,108 $17.3 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $377,044 - $429,871	9,801 Added 2.4%	418,569 $18.3 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $136,363 - $165,400	3,956 Added 0.98%	408,768 $18 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $142,704 - $152,137	4,327 Added 1.08%	404,812 $14.7 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $666,663 - $773,421	20,892 Added 5.5%	400,485 $14.2 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $397,157 - $421,397	11,941 Added 3.25%	379,593 $13.7 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $380,680 - $419,362	12,280 Added 3.46%	367,652 $13.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	355,372	355,372 $11.9 Million

Others Institutions Holding PFE

# of Institutions

3,240

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $158B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.

Account

Waters Parkerson & Co., LLC Pfizer Inc Transaction History